Bacterial CagA protein compromises tumor suppressor mechanisms in gastric epithelial cells.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
01 05 2020
Historique:
received: 03 05 2019
accepted: 22 01 2020
pubmed: 7 4 2020
medline: 27 1 2021
entrez: 7 4 2020
Statut: ppublish

Résumé

Approximately half of the world's population is infected with the stomach pathogen Helicobacter pylori. Infection with H. pylori is the main risk factor for distal gastric cancer. Bacterial virulence factors, such as the oncoprotein CagA, augment cancer risk. Yet despite high infection rates, only a fraction of H. pylori-infected individuals develop gastric cancer. This raises the question of defining the specific host and bacterial factors responsible for gastric tumorigenesis. To investigate the tumorigenic determinants, we analyzed gastric tissues from human subjects and animals infected with H. pylori bacteria harboring different CagA status. For laboratory studies, well-defined H. pylori strain B128 and its cancerogenic derivative strain 7.13, as well as various bacterial isogenic mutants were employed. We found that H. pylori compromises key tumor suppressor mechanisms: the host stress and apoptotic responses. Our studies showed that CagA induces phosphorylation of XIAP E3 ubiquitin ligase, which enhances ubiquitination and proteasomal degradation of the host proapoptotic factor Siva1. This process is mediated by the PI3K/Akt pathway. Inhibition of Siva1 by H. pylori increases survival of human cells with damaged DNA. It occurs in a strain-specific manner and is associated with the ability to induce gastric tumor.

Identifiants

pubmed: 32250340
pii: 130015
doi: 10.1172/JCI130015
pmc: PMC7190987
doi:
pii:

Substances chimiques

Antigens, Bacterial 0
Apoptosis Regulatory Proteins 0
Bacterial Proteins 0
Neoplasm Proteins 0
SIVA1 protein, human 0
X-Linked Inhibitor of Apoptosis Protein 0
XIAP protein, human 0
cagA protein, Helicobacter pylori 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2422-2434

Subventions

Organisme : NCI NIH HHS
ID : P01 CA028842
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA206564
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI142042
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK058404
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA116087
Pays : United States
Organisme : BLRD VA
ID : I01 BX001453
Pays : United States
Organisme : BLRD VA
ID : I01 BX002115
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA077955
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA190612
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA138833
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA068485
Pays : United States
Organisme : CSRD VA
ID : I01 CX002171
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Gut. 2015 Jul;64(7):1040-8
pubmed: 25080447
J Gastroenterol. 2002;37 Suppl 13:10-6
pubmed: 12109657
Nat Commun. 2013;4:1551
pubmed: 23462994
J Biol Chem. 2004 Jul 2;279(27):28706-14
pubmed: 15105421
Cancer. 2002 Aug 1;95(3):499-505
pubmed: 12209741
Cell. 1994 Sep 9;78(5):787-98
pubmed: 8087846
Cancer Res. 1995 May 15;55(10):2111-5
pubmed: 7743510
J Med Microbiol. 2008 Feb;57(Pt 2):145-150
pubmed: 18201978
Cancer Res. 2003 Mar 1;63(5):942-50
pubmed: 12615707
J Virol. 2000 May;74(9):4284-90
pubmed: 10756043
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Leukemia. 2017 Feb;31(2):502-505
pubmed: 27773928
Gut. 2011 Sep;60(9):1189-95
pubmed: 21357593
Biochim Biophys Acta. 2009 Apr;1793(4):664-73
pubmed: 18706940
J Biol Chem. 2007 Dec 28;282(52):37759-69
pubmed: 17965021
J Clin Invest. 1998 Oct 15;102(8):1506-14
pubmed: 9788963
BMC Microbiol. 2011 May 27;11:121
pubmed: 21619658
Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10646-51
pubmed: 16027366
Gastroenterology. 2011 Jan;140(1):199-209
pubmed: 20600031
PLoS Pathog. 2012;8(10):e1002939
pubmed: 23093933
Dig Dis Sci. 1999 Mar;44(3):487-93
pubmed: 10080139
Cancer Res. 1996 Mar 15;56(6):1279-82
pubmed: 8640814
Gastroenterology. 2019 Jan;156(1):160-174.e7
pubmed: 30287170
PLoS Pathog. 2015 Sep 17;11(9):e1005099
pubmed: 26379246
J Cell Physiol. 2007 Jul;212(1):118-25
pubmed: 17348035
Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):1003-8
pubmed: 18192401
Ned Tijdschr Geneeskd. 1995 Apr 8;139(14):709-12
pubmed: 7731465
Gastroenterology. 2010 Oct;139(4):1333-43
pubmed: 20547161
Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14944-9
pubmed: 21896770
Clin Cancer Res. 2012 Aug 1;18(15):4201-12
pubmed: 22675170
Science. 1998 Nov 20;282(5393):1497-501
pubmed: 9822382
Cell Host Microbe. 2014 Mar 12;15(3):306-16
pubmed: 24629337
Cell Rep. 2015 Oct 6;13(1):70-79
pubmed: 26411687
Proc Natl Acad Sci U S A. 2002 May 14;99(10):6925-30
pubmed: 12011449
Cancer Discov. 2015 Jun;5(6):622-35
pubmed: 25813352
J Physiol. 2018 Sep;596(17):3861-3867
pubmed: 29427515
Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12851-6
pubmed: 21768358
Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6346-51
pubmed: 9177220
J Natl Cancer Inst. 1997 Jun 18;89(12):863-8
pubmed: 9196252
Apoptosis. 2011 Jan;16(1):35-44
pubmed: 20812030
Nat Rev Gastroenterol Hepatol. 2018 May;15(5):257-273
pubmed: 29463907
Biochem Biophys Res Commun. 1997 Oct 20;239(2):626-32
pubmed: 9344882
Gastroenterology. 2017 Aug;153(2):420-429
pubmed: 28456631
Oncogene. 2018 Sep;37(37):5054-5065
pubmed: 29849123
Int J Biochem Cell Biol. 2016 Oct;79:403-418
pubmed: 27448843
DNA Cell Biol. 2019 Mar;38(3):272-280
pubmed: 30657337
Science. 2000 Feb 25;287(5457):1497-500
pubmed: 10688800
Dis Model Mech. 2013 May;6(3):802-10
pubmed: 23471915
J Cell Sci. 2009 Aug 1;122(Pt 15):2651-61
pubmed: 19584092
Cancer Res. 1999 Dec 15;59(24):6124-31
pubmed: 10626802

Auteurs

Manikandan Palrasu (M)

Department of Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.

Elena Zaika (E)

Department of Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.

Wael El-Rifai (W)

Department of Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Department of Veterans Affairs, Miami VA Healthcare System, Miami, Florida, USA.

Monica Garcia-Buitrago (M)

Department of Pathology, University of Miami Miller School of Medicine, Miami, Florida, USA.

Maria Blanca Piazuelo (MB)

Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Keith T Wilson (KT)

Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Department of Veterans Affairs, VA Tennessee Valley Health Care System, Nashville, Tennessee, USA.

Richard M Peek (RM)

Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Alexander I Zaika (AI)

Department of Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Department of Veterans Affairs, Miami VA Healthcare System, Miami, Florida, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH